Triggering TLR2, -3, -4, -5, and -8 reinforces the restrictive nature of M1- and M2-polarized macrophages to HIV

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9769-9781

  Schlaepfer, Erika ^a   Rochat, Mary Aude ^a   Duo, Li ^a   Speck, Roberto F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TOLL LIKE RECEPTOR;

AGONISTS; DRUG EFFECTS; ENDOCYTOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MACROPHAGE; SECRETION (PROCESS); VIROLOGY;

CYTOKINES; ENDOCYTOSIS; HIV-1; HUMANS; MACROPHAGES; TOLL-LIKE RECEPTORS;

EID: 84919429177     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01053-14     Document Type: Article

References (37)

1. Pluddemann A, Mukhopadhyay S, Gordon S. 2011. Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry. Immunol. Rev. 240:11-24. http://dx.doi.org/10.1111/j.1600-065X.2010.00989.x.
2. Sica A, Mantovani A. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122:787-795. http://dx.doi.org/10.1172/JCI59643.
3. Zhu J, Mohan C. 2010. Toll-like receptor signaling pathways-therapeutic opportunities. Mediators Inflamm. 2010:781235. http://dx.doi.org/10.1155/2010/781235.
4. Sasai M, Yamamoto M. 2013. Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors. Int. Rev. Immunol. 32:116-133. http://dx.doi.org/10.3109/08830185.2013.774391.
5. McCoy CE, O'Neill LA. 2008. The role of Toll-like receptors in macrophages. Front. Biosci. 13:62-70. http://dx.doi.org/10.2741/2660.
6. Koppensteiner H, Brack-Werner R, Schindler M. 2012. Macrophages and their relevance in human immunodeficiency virus type I infection. Retrovirology 9:82. http://dx.doi.org/10.1186/1742-4690-9-82.
7. Mantovani A, Sica A, Locati M. 2005. Macrophage polarization comes of age. Immunity 23:344-346. http://dx.doi.org/10.1016/j.immuni.2005.10.001.
8. Martinez FO, Sica A, Mantovani A, Locati M. 2008. Macrophage activation and polarization. Front. Biosci. 13:453-461. http://dx.doi.org/10.2741/2692.
9. Cassol E, Cassetta L, Rizzi C, Alfano M, Poli G. 2009. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J. Immunol. 182:6237-6246. http://dx.doi.org/10.4049/jimmunol.0803447.
10. Herbein G, Varin A. 2010. The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7:33. http://dx.doi.org/10.1186/1742-4690-7-33.
11. Graziosi C, Gantt KR, Vaccarezza M, Demarest JF, Daucher M, Saag MS, Shaw GM, Quinn TC, Cohen OJ, Welbon CC, Pantaleo G, Fauci AS. 1996. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc. Natl. Acad. Sci. U. S. A. 93:4386-4391. http://dx.doi.org/10.1073/pnas.93.9.4386.
12. Biglino A, Sinicco A, Forno B, Pollono AM, Sciandra M, Martini C, Pich P, Gioannini P. 1996. Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin. Immunol. Immunopathol. 78:61-69. http://dx.doi.org/10.1006/clin.1996.0009.
13. Liovat AS, Rey-Cuille MA, Lecuroux C, Jacquelin B, Girault I, Petitjean G, Zitoun Y, Venet A, Barre-Sinoussi F, Lebon P, Meyer L, Sinet M, Muller-Trutwin M. 2012. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One 7:e46143. http://dx.doi.org/10.1371/journal.pone.0046143.
14. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371. http://dx.doi.org/10.1038/nm1511.
15. Hofer U, Speck RF. 2009. Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin. Immunopathol. 31:257-266. http://dx.doi.org/10.1007/s00281-009-0158-3.
16. Hofer U, Schlaepfer E, Baenziger S, Nischang M, Regenass S, Schwendener R, Kempf W, Nadal D, Speck RF. 2010. Inadequate clearance of translocated bacterial products in HIV-infected humanized mice. PLoS Pathog. 6:e1000867. http://dx.doi.org/10.1371/journal.ppat.1000867.
17. Chan SY, Speck RF, Ma MC, Goldsmith MA. 2000. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Virol. 74:4933-4937. http://dx.doi.org/10.1128/JVI.74.10.4933-4937.2000.
18. Schaefer BC, Mitchell TC, Kappler JW, Marrack P. 2001. A novel family of retroviral vectors for the rapid production of complex stable cell lines. Anal. Biochem. 297:86-93. http://dx.doi.org/10.1006/abio.2001.5327.
19. Moore JP, McKeating JA, Weiss RA, Sattentau QJ. 1990. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250:1139-1142. http://dx.doi.org/10.1126/science.2251501.
20. Audige A, Schlaepfer E, Bonanomi A, Joller H, Knuchel MC, Weber M, Nadal D, Speck RF. 2004. HIV-1 does not provoke alteration of cytokine gene expression in lymphoid tissue after acute infection ex vivo. J. Immunol. 172:2687-2696. http://dx.doi.org/10.4049/jimmunol.172.4.2687.
21. Muller PY, Janovjak H, Miserez AR, Dobbie Z. 2002. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32:1372-1374, 1376, 1378-1379.
22. VignaliDA.2000.Multiplexedparticle-basedflowcytometric assays. J.Immunol. Methods 243:243-255. http://dx.doi.org/10.1016/S0022-1759(00)00238-6.
23. Gendelman HE, Friedman RM, Joe S, Baca LM, Turpin JA, Dveksler G, Meltzer MS, Dieffenbach C. 1990. A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J. Exp. Med. 172:1433-1442. http://dx.doi.org/10.1084/jem.172.5.1433.
24. Gobeil LA, Lodge R, Tremblay MJ. 2013. Macropinocytosis-like HIV-1 internalization in macrophages is CCR5 dependent and leads to efficient but delayed degradation in endosomal compartments. J. Virol. 87:735-745. http://dx.doi.org/10.1128/JVI.01802-12.
25. Berthiaume EP, Medina C, Swanson JA. 1995. Molecular sizefractionation during endocytosis in macrophages. J. Cell Biol. 129:989-998. http://dx.doi.org/10.1083/jcb.129.4.989.
26. Cobos Jimenez V, Booiman T, de Taeye SW, van Dort KA, Rits MA, Hamann J, Kootstra NA. 2012. Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons. Sci. Rep. 2:763. http://dx.doi.org/10.1038/srep00763.
27. Schuitemaker H, Kootstra NA, Koppelman MH, Bruisten SM, Huisman HG, Tersmette M, Miedema F. 1992. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J. Clin. Invest. 89:1154-1160. http://dx.doi.org/10.1172/JCI115697.
28. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169:1137-1151. http://dx.doi.org/10.1084/jem.169.3.1137.
29. Swaminathan G, Rossi F, Sierra LJ, Gupta A, Navas-Martin S, Martin-Garcia J. 2012. A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages. PLoS Pathog. 8:e1002937. http://dx.doi.org/10.1371/journal.ppat.1002937.
30. Campbell GR, Spector SA. 2012. Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Pathog. 8:e1003017. http://dx.doi.org/10.1371/journal.ppat.1003017.
31. Victoria S, Temerozo JR, Gobbo L, Pimenta-Inada HK, Bou-Habib DC. 2013. Activation of Toll-like receptor 2 increases macrophage resistance to HIV-1 infection. Immunobiology 218:1529-1536. http://dx.doi.org/10.1016/j.imbio.2013.06.006.
32. Martinez FO, Gordon S, Locati M, Mantovani A. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177:7303-7311. http://dx.doi.org/10.4049/jimmunol.177.10.7303.
33. Carter GC, Bernstone L, Baskaran D, James W. 2011. HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 409:234-250. http://dx.doi.org/10.1016/j.virol.2010.10.018.
34. Hughes R, Towers G, Noursadeghi M. 2012. Innate immune interferon responses to human immunodeficiency virus-1 infection. Rev. Med. Virol. 22:257-266. http://dx.doi.org/10.1002/rmv.1708.
35. Zhou D, Mei Q, Li J, He H. 2012. Cyclophilin A and viral infections. Biochem. Biophys. Res. Commun. 424:647-650. http://dx.doi.org/10.1016/j.bbrc.2012.07.024.
36. Verani A, Scarlatti G, Comar M, Tresoldi E, Polo S, Giacca M, Lusso P, Siccardi AG, Vercelli D. 1997. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185:805-816. http://dx.doi.org/10.1084/jem.185.5.805.
37. d'Ettorre G, Paiardini M, Ceccarelli G, Silvestri G, Vullo V. 2011. HIV-associated immune activation: from bench to bedside. AIDS Res. Hum. Retroviruses 27:355-364. http://dx.doi.org/10.1089/aid.2010.0342.